✦ LIBER ✦

Randomized Trial of Adjuvant Zoledronic Acid in Postmenopausal Women With High-Risk Breast Cancer

✍ Scribed by Ticiana Leal; Amyé Tevaarwerk; Richard Love; James Stewart; Neil Binkley; Jens Eickhoff; Benjamin Parrot; Daniel Mulkerin

Book ID: 115075890
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 562 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

The AZURE trial – does adjuvant zoledron

The AZURE trial – does adjuvant zoledronic acid reduce recurrence in patients with high-risk localised breast cancer?

✍ R. Burkinshaw; H. Thorpe; S. Pollard; R. Bell; D. Dodwell; D. Cameron; R. Colema 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

4–49 Zoledronic Acid Inhibits Adjuvant L

4–49 Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Efficacy of zoledronic acid in postmenop

Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results

✍ Shunji Takahashi, Takuji Iwase, Norio Kohno, Takashi Ishikawa, Tetsuya Taguchi, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 337 KB

Do adjuvant aromatase inhibitors increas

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version